Get startedLog in
    Picture of Egetis Therapeutics AB (publ) logo

    EGTX — Egetis Therapeutics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Egetis Therapeutics Gets Medicine Designation In UK For Emcitate®

    Picture of Egetis Therapeutics AB (publ) logoEgetis Therapeutics AB (publ)
    03/06/2024 06:12
    June 3 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * AWARDED PROMISING INNOVATIVE MEDICINE DESIGNATION IN UK
FOR
EMCITATE® (TIRATRICOL) FOR TREATMENT OF MCT8 DEFICIENCY

Source text for Eikon:  ID:nMFN4yg5QC 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Egetis Therapeutics AB (publ)

    See all news